1887

Abstract

infects the human gastric mucosa and elicits an aggressive inflammatory response. Despite the severity of the inflammatory response, the bacterium is able to persist and cause a chronic infection. It is believed that antioxidant defence mechanisms enable this organism to persist. Wild-type strain SS1, and KatA- and KapA-deficient mutants, were used to infect C57/BL6 mice to test this hypothesis. Neither KatA nor KapA was essential for the initial colonization of SS1 in the murine model of infection. The wild-type SS1 colonized the gastric mucosa at significantly higher levels than both mutants throughout the 24-week experiment. Neither KatA- nor KapA-deficient mutants were able to maintain consistent ongoing colonization for the 24-week period, indicating the necessity of both KapA and KatA in sustaining a long-term infection. At 24 weeks, 5/10 mice inoculated with the KatA mutant and 2/10 mice inoculated with the KapA mutant were colonized, compared with 10/10 of the mice inoculated with the wild-type SS1. An increase in the severity of inflammation in the wild-type-inoculated mice appeared to correlate with the decline in colonization of animals inoculated with the mutants, suggesting that increased oxidative stress militated against continued infection by the mutants. These data indicate that KapA may be of equal or greater importance than KatA in terms of sustained infection on inflamed gastric mucosae.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.26012-0
2003-03-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/micro/149/3/mic149665.html?itemId=/content/journal/micro/10.1099/mic.0.26012-0&mimeType=html&fmt=ahah

References

  1. Alm, R., Ling, L., Moir, D. & 20 other authors ( 1999; ). Genomic sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397, 176–180.[CrossRef]
    [Google Scholar]
  2. Beers, R. & Sizer, I. ( 1952; ). A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195, 133–140.
    [Google Scholar]
  3. Cadenas, E. ( 1989; ). Biochemistry of oxygen toxicity. Annu Rev Biochem 58, 79–110.[CrossRef]
    [Google Scholar]
  4. Crabtree, J. ( 1996; ). Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 31, 3–10.
    [Google Scholar]
  5. Dixon, M. F. ( 2001; ). Patterns of inflammation linked to ulcer disease. Best Pract Res Clin Gastroenterol 14, 27–40.
    [Google Scholar]
  6. Enno, A., O'Rourke, J., Braye, S., Howlett, R. & Lee, A. ( 1998; ). Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice. Am J Pathol 152, 1625–1632.
    [Google Scholar]
  7. Forman, D., Newell, D. G., Fullerton, F., Yarnell, J. W., Stacy, A. R., Wald, N. & Sitas, F. ( 1991; ). Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 302, 1302–1305.[CrossRef]
    [Google Scholar]
  8. Frommer, D., Carrick, J., Lee, A. & Hazell, S. ( 1988; ). Acute presentation of Campylobacter pylori gastritis. Am J Gastroenterol 83, 1168–1171.
    [Google Scholar]
  9. Graham, D. ( 1989; ). Campylobacter pylori and peptic ulcer disease. Gastroenterology 96, 615–625.
    [Google Scholar]
  10. Harris, A., Hazell, S. & Netting, A. ( 2000; ). Use of Digoxigenin-labelled ampicillin in the identification of penicillin binding proteins in Helicobacter pylori. J Antimicrob Chemother 45, 591–598.[CrossRef]
    [Google Scholar]
  11. Harris, A. G., Hinds, F. E., Beckhouse, A. G., Kolesniow, T. & Hazell, S. L. ( 2002; ). Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated ‘KatA-associated protein’, KapA (HP0874). Microbiology 148, 3813–3825.
    [Google Scholar]
  12. Hazell, S., Hennessy, W., Borody, T., Carrick, J., Ralston, M., Brady, L. & Lee, A. ( 1987; ). Campylobacter pyloridis gastritis. II.: Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol 82, 297–300.
    [Google Scholar]
  13. Hazell, S., Evans, D. & Graham, D. ( 1991a; ). Helicobacter pylori catalase. J Gen Microbiol 137, 57–61.[CrossRef]
    [Google Scholar]
  14. Hazell, S. L., Evans, D. J., Jr, Evans, D. G. & Graham, D. Y. ( 1991b; ). Campylobacter pylori catalase: a putative virulence factor. In Campylobacter V (Proceedings of the Vth International Workshop on Campylobacter Infection, Mexico City), pp. 367–368. Edited by G. M. Ruiz-Palacios, E. Calva & B. R. Ruiz-Palacios.
  15. Hazell, S. L., Harris, A. G. & Trend, M. A. ( 2001; ). Evasion and avoidance of the toxic effects of oxygen, (eds). In Helicobacter pylori: Physiology and Genetics, pp. 167–175. Edited by H. L. T. Mobley, G. L. Mendz, & S. L. Hazell. Washington, DC: American Society for Microbiology.
  16. Howell, M. L., Alsabbagh, E., Ma, J. F. & 10 other authors ( 2000; ). AnkB, a periplasmic ankyrin-like protein in Pseudomonas aeruginosa, is required for optimal catalase B (KatB) activity and resistance to hydrogen peroxide. J Bacteriol 182, 4545–4556.[CrossRef]
    [Google Scholar]
  17. Lee, A. ( 2000; ). Animal models of gastroduodenal ulcer disease. Best Pract Res Clin Gastroenterol 14, 75–96.[CrossRef]
    [Google Scholar]
  18. Lee, A., O'Rourke, J., De Ungria, M. C., Robertson, B., Daskalopoulos, G. & Dixon, M. F. ( 1997; ). A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112, 1386–1397 [an erratum appears in Gastroenterology 113, 732].[CrossRef]
    [Google Scholar]
  19. Manos, J., Kolesnikow, T. & Hazell, S. L. ( 1997; ). An investigation of the molecular basis of the spontaneous occurrence of a catalase negative phenotype in Helicobacter pylori. Helicobacter 3, 28–38.
    [Google Scholar]
  20. McColm, A. A., Bagshaw, J., O'Mally, C. & McLaren, A. ( 1995; ). Development of a mouse model of gastric colonization with Helicobacter pylori. Gut 37, A50.[CrossRef]
    [Google Scholar]
  21. Odenbreit, S., Wieland, B. & Haas, R. ( 1996; ). Cloning and genetic characterisation of Helicobacter pylori catalase and construction of a catalase deficient mutant. J Bacteriol 178, 6960–6967.
    [Google Scholar]
  22. Parsonnet, J., Friedman, G., Vandersteen, D., Chang, Y., Vogelman, J., Orenteich, N. & Sibley, R. ( 1991; ). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325, 1127–1131.[CrossRef]
    [Google Scholar]
  23. Radcliff, F. J., Hazell, S. L., Kolesnikow, T., Doidge, C. & Lee, A. ( 1997; ). Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun 65, 4668–4674.
    [Google Scholar]
  24. Ramarao, N., Gray-Owen, S. D. & Meyer, T. F. ( 2000; ). Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol Microbiol 36, 103–113.
    [Google Scholar]
  25. Seyler, R. W., Olson, J. W. & Maier, R. J. ( 2001; ). Superoxide-dismutase deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect Immun 69, 4034–4040.[CrossRef]
    [Google Scholar]
  26. Skirrow, M. ( 1977; ). Campylobacter enteritis: a “new” disease. Br Med J 2, 9–11.[CrossRef]
    [Google Scholar]
  27. Sutton, P., Kolesniow, T., Danon, S., Wilson, J. & Lee, A. ( 2000; ). Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin-10 but not gamma interferon. Infect Immun 68, 4802–4804.[CrossRef]
    [Google Scholar]
  28. Tomb, J., White, O., Kerlavage, A. & 39 other authors ( 1997; ). The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539–547.[CrossRef]
    [Google Scholar]
  29. Uemura, N., Okamoto, S., Yamamoto, S., Matsumara, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N. & Schlemper, R. J. ( 2001; ). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345, 784–789.[CrossRef]
    [Google Scholar]
  30. Westblom, T., Phadnis, S., Langenberg, W., Yoneda, K., Madan, E. & Midkiff, B. ( 1992; ). Catalase negative mutants of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 11, 522–526.[CrossRef]
    [Google Scholar]
  31. Wotherspoon, A., Ortitz-Hidalgo, C., Falzon, M. & Isaacson, P. ( 1991; ). Helicobacter pylori associated gastritis and B-cell gastric lymphoma. Lancet 338, 1175–1176.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.26012-0
Loading
/content/journal/micro/10.1099/mic.0.26012-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error